Amneal Reports First Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/12/2026
- Wall Street ends higher as investors turn to earnings season
- Oil prices settle lower on hopes for smoother shipping in Strait of Hormuz
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Almonty Industries (ALM) PT Raised to $33 at DA Davidson
- JPMorgan analysts name top short ideas for third quarter 2026
- The real reason Meta shares are surging has nothing to do with its new AI model
- Wall Street ends higher as investors turn to earnings season
- AppLovin gains market share among e-commerce advertisers
Amneal Pharmaceuticals (AMRX) Tops Q1 EPS by 11c, Offers FY Guidance
May 11, 2020 6:36 AM EDTAmneal Pharmaceuticals (: AMRX) reported Q1 EPS of $0.20, $0.11 better than the analyst estimate of $0.09. Revenue for the quarter came in at $499 million versus the consensus estimate of $444.23 million.
GUIDANCE:
Amneal Pharmaceuticals sees FY2020 EPS of $0.45-$0.60, versus the consensus of $0.49. Amneal... More
